LAUSR

BACKGROUND AND PURPOSE: Percutaneous thermal ablation followed by vertebral augmentation is an emerging minimally invasive therapeutic alternative for the management of spinal metastases. This study aimed to retrospectively evaluate the effectiveness and safety of microwave ablation combined with vertebral augmentation for the treatment of painful vertebral metastases. MATERIALS AND METHODS: Overall, 91 patients with 140 metastatic vertebrae who experienced refractory moderate-to-severe pain were treated with CT-guided microwave ablation and vertebral augmentation. Procedural effectiveness was determined using the visual analog scale, daily morphine consumption, and the Oswestry Disability Index preprocedurally and during follow-up. Local tumor control was assessed at follow-up imaging. RESULTS: The procedure was technically successful in all patients. The median visual analog scale score and mean morphine dose were 6 (range, 4–10) and 77.8 (SD, 31.5) mg (range, 15–143 mg), preprocedurally; 5 (range 3–8) and 34.5 (SD, 23.8) mg (range, 0–88 mg) at 3 days; 4 (range, 2–7) and 28.7 (SD, 16.4) mg (range, 0–73 mg) at 1 week; 3 (range, 1–6) and 24.6 (SD, 13.2) mg (range, 0–70 mg) at 1 month; 3 (range, 1–6) and 21.70 (SD, 10.0) mg (range, 0–42 mg) at 3 months; and 3 (range, 1–8) and 21.0 (SD, 9.9) mg (range, 0–46 mg) at 6 months postprocedurally (all P < .05). A decrease in the Oswestry Disability Index score was also observed (P < .01). Local control was achieved in 94.8% of the treated metastatic vertebrae during the 6-month follow-up period. Asymptomatic cement leakage occurred in 42 (30%) treated vertebrae. A grade 3 neural injury was observed in 1 patient (1.1%). The patient’s neurologic function returned to normal following treatment with mannitol, glucocorticoids, and radiation therapy. CONCLUSIONS: This study demonstrates that percutaneous CT-guided microwave ablation combined with vertebral augmentation is a safe and effective minimally invasive intervention for the treatment of painful spinal metastases.